New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Investment is additive to KKR’s existing health care growth strategy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Subscribe To Our Newsletter & Stay Updated
